Key facts
| Price (PPV) | 119.50 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | etoricoxib |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AH05 |
| Manufacturer | COOPER PHARMA |
| Presentation | Boite de 14 |
| Hospital price | 74.70 MAD |
| Data collected on | 9/8/2026 |
Indications
L’étoricoxib est indiqué dans le traitement symptomatique des inflammations et douleurs chez les patients souffrant d'arthrose. La décision de prescrire un inhibiteur sélectif de la COX-2 doit s'appuyer sur l'évaluation de l'ensemble des risques spécifiques à chaque patient.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Arcoxia 60 mg (MAPHAR) contains the same active substance as Arixib 60 mg (Etoricoxib) at the same strength, but in a different pack: Boîte de 7 at 65.20 MAD, i.e. 9.31 MAD per unit against 8.54 MAD for Arixib 60 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Arcoxia 60 mg | MAPHAR | Boîte de 14 | 119.50 MAD | 8.54 / unit | — |
| Dolicox 60 mg | BOTTU S.A. | Boite de 14 | 119.50 MAD | 8.54 / unit | — |
| Storixia 60 mg | SOTHEMA | Boite de 14 | 119.50 MAD | 8.54 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Arcoxia 60 mg | MAPHAR | Boîte de 7 | 65.20 MAD | 9.31 / unit |
| Arixib 60 mg | COOPER PHARMA | Boite de 7 | 65.20 MAD | 9.31 / unit |
| Dolicox 60 mg | BOTTU S.A. | Boite de 7 | 65.20 MAD | 9.31 / unit |
| Storixia 60 mg | SOTHEMA | Boite de 7 | 65.20 MAD | 9.31 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Arixib 60 mg
Arixib 60 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by COOPER PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Arixib 60 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Arixib 60 mg
Answers to common questions from Moroccan patients about this drug.